UNSPSC 51292926: Opipramol dihydrochloride

This classification denotes an anxiolytic and antidepressant agent with the molecular formula C23H29N3O.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B49OBI656M, chemically known as 1-piperazineethanol, 4-(3-(5h-dibenz(b,f)azepin-5-yl)propyl)-, dihydrochloride, but more generally known as opipramol dihydrochloride, which bears US NIH Compound Identifier 71587. European Medicines Agency schedules opipramol dihydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09450MIG.

Most nations, for tariff purposes, schedule opipramol dihydrochloride under HS 29335995. SMILES: C1CCC2C(C1)C=CC3CCCCC3N2CCCN4CCN(CC4)CCO.CL.CL.

UNSPSC 51292926 Opipramol dihydrochloride is a Commodity code for a specific pharmaceutical product, but the recent state and local procurement activity tagged to this code does not reflect purchases of opipramol. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking to procure naloxone and drug deactivation systems — products unrelated to the code's nominal scope. The mismatch suggests either a tagging error in the county's procurement system or a broader misalignment between the UNSPSC category and actual solicitation activity.

The single recent opportunity on record — Seminole County's naloxone and deactivation-systems bid with a response deadline of July 26, 2023 — does not establish meaningful procurement activity under this Commodity code. The source provides no evidence of state and local demand for opipramol dihydrochloride itself, no issuing-body pattern, and no geographic concentration. Practitioners evaluating this code should verify whether the UNSPSC classification reflects actual pharmaceutical procurement by state and local health departments or whether the tagging represents an isolated data entry error.